BeyondSpring Inc. (BYSI)
Nasdaq: BYSI · Pharmaceutical Preparations · Florham Park, NJ · filing with the SEC since 2016
Who owns BeyondSpring Inc.
As filed with the SECHolders of 5% or more
3
Lan Huang holds 15% of Ordinary Shares, par value $0.0001 per share, as its SCHEDULE 13G/A filed Feb 14, 2025 says.
Directors and officers
9
report now, of 9 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Lan Huang
SCHEDULE 13G/A · filed Feb 14, 2025 · Ordinary Shares, par value $0.0001 per share
Lan Huang
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares, par value $0.0001 per share · 14.1% in May 15, 2026
Xiangmin Cui
SCHEDULE 13G/A · filed Feb 13, 2026 · Ordinary Shares, par value $0.0001 per share · 11.2% in Aug 14, 2025
What BYSI reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Seed
An entity · legal entity · owns, named in the 10-K filed Mar 25, 2026
SEED Therapeutics Inc.
An entity · legal entity · owns, named in the 10-K filed Mar 25, 2026
13 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 25, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window4 of 16 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Decheng Capital Global Healthcare Gp, LLC | 10% owner | 6 | $300,000 | 0 | 0 | $0 |
| Decheng Capital China Life Sciences Usd Fund II, L.P. | 10% owner | 2 | $200,000 | 0 | 0 | $0 |
| Cui Xiangmin | 10% owner | 3 | $0 | 0 | 0 | $0 |
| Decheng Capital Management III (Cayman), LLC | 10% owner | 3 | $0 | 0 | 0 | $0 |